Bafna Pharmaceuticals Ltd reported a significant increase in net profit of 354.51% and net sales rose by 63.68% for Q2, ending 30 September 2012. The company's equity capital increased by 6.72%, and the net profit margin improved to 3.55% from 1.28% in the previous fiscal year. The stock closed at 47.00, reflecting a gain of 1.95% from the previous close despite a slight decline in major indices.

1. Bafna Pharma Q2 Net rises 355%
Bafna Pharmaceuticals Ltd
31-Dec-2012 | Quarterly Result as on 30-Sep-2012
For the period the Bafna Pharmaceuticals Ltd reported Net Sales of Rs 581.93 million and Net Profit of Rs 20.68 million. While Net Sales
rose by 63.68%, Net Profit grown by 354.51% and thereby NPM improved to 3.55% as compared to 1.28% during same period previous FY .
Equity Capital for the period under consideration has increased by 6.72% and stands at Rs 186.56 million.
The stock of the Bafna Pharmaceuticals Ltd at BSE opened at 46.00 touched a high 47.50 and low 45.30 before closing at 47.00 gaining
1.95% over previous close. The trading volume for the stock at BSE stood at 25137 shares and at NSE stood at 16022 shares.
BSE NSE
The BSE Sensex closed today at 19426.71 (0.09% loss) and Nifty closed at 5905.10 (0.06% loss).
View Detailed Result
Follow us on This content is generated at www.finalaya.com and is governed by the Terms of Use.